MedTrace Logo

Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance

NCT06090487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-09-05

No results posted yet for this study

Summary

The aim of this study is to assess whether sacubitril-valsartan is more effective than dapagliflozin in improving function, myocardial performance in patients undergoing CABG operation or not

Conditions

Interventions

DIAGNOSTIC_TEST

myocardial function after surgery

This group includes (15) patients who will have 200 mg twice daily oral (5) sacubitril-valsartan 1 month before the operation. transthoracic echo will be done before and after surgery, also total dose if inoptropic drugs will be noted

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • amr gaber, lecturer · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06090487 on ClinicalTrials.gov